This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Rohit Lowalekar: Innovator in Pharmaceutical Formulations
Introduction
Rohit Lowalekar is a notable inventor based in Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in developing formulations that address serious respiratory conditions. His work is characterized by a commitment to improving patient outcomes through innovative solutions.
Latest Patents
Rohit Lowalekar holds a patent for the formulation of (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide. This patent describes compounds and pharmaceutical compositions that are useful for treating bronchiectasis, chronic obstructive pulmonary disorder, cystic fibrosis, chronic bronchitis, or asthma. The formulations aim to provide a therapeutically effective amount of the compound to subjects in need, showcasing his dedication to addressing critical health issues.
Career Highlights
Rohit has established himself as a valuable asset in the pharmaceutical industry, working with Novartis AG. His role in the company allows him to leverage his expertise in drug formulation and development, contributing to the advancement of medical treatments.
Collaborations
Throughout his career, Rohit has collaborated with talented professionals, including Vivek Dubey and Paulo G Santos. These collaborations have fostered an environment of innovation and shared knowledge, enhancing the impact of their collective work in the pharmaceutical sector.
Conclusion
Rohit Lowalekar's contributions to pharmaceutical formulations demonstrate his commitment to innovation and improving healthcare. His patent and collaborations reflect a dedication to addressing significant medical challenges, making him a noteworthy figure in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
